Provided by Tiger Fintech (Singapore) Pte. Ltd.

Conduit Pharmaceuticals Inc.

1.09
+0.08007.92%
Post-market: 1.110.0200+1.83%19:59 EDT
Volume:538.13K
Turnover:574.16K
Market Cap:5.13M
PE:-0.05
High:1.12
Open:1.02
Low:1.01
Close:1.01
Loading ...

Company Profile

Company Name:
Conduit Pharmaceuticals Inc.
Exchange:
NASDAQ
Establishment Date:
2019
Employees:
7
Office Location:
4995 Murphy Canyon Road,Suite 300,San Diego,California,United States
Zip Code:
92123
Fax:
- -
Introduction:
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Directors

Name
Position
David Tapolczay
Chief Executive Officer and Director
Freda Lewis Hall
Chairperson of the Board
James Bligh
Interim Chief Financial Officer, Senior Vice President – Strategy and Director
Andrew Regan
Director
Chele Chiavacci Farley
Director
Faith L. Charles
Director

Shareholders

Name
Position
David Tapolczay
Chief Executive Officer and Director
James Bligh
Interim Chief Financial Officer, Senior Vice President – Strategy and Director